
Semarion
A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.
About
Semarion develops SemaCyte® microcarriers, which are ultra-miniaturised, barcoded micro-wells that enable adherent cells to become assay-ready reagents. This technology allows for the multiplexing of cell models in standard liquid handling workflows, facilitating faster, more scalable, and comparable cell-based experiments for in vitro drug discovery. Semarion serves teams looking to generate better data and accelerate drug discovery by removing bottlenecks in adherent cell screening.
Listed competitors
Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.
Global biopharmaceutical company focused on oncology and neuroscience treatments.
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Also in this space
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Life Sciences
A vertically-integrated procurement platform for the life sciences industry.
Shares Biotechnology, Life Sciences
A global leader in clinical pharmacology and bioanalytical sciences.
Shares Biotechnology, Life Sciences
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Shares Biotechnology, Biotech
Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
Shares Biotechnology, Drug Discovery
The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
Shares Biotechnology, Life Sciences
“I'm very interested in how automation is being used in T cell engineering/cell therapy manufacturing and i was wondering what you guys…” r/biotech
Key facts
- Website
- semarion.com
- Headquarters
- Cambridge, England, United Kingdom
- Founded
- 2018
- Employees
- 12
- Total funding
- $9M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 30 Mar 2026 | Funding Round | $4M | Parkwalk Advisors |
| 17 Mar 2025 | Pre-Series A | $2M | |
| 22 Feb 2022 | Seed | $3M | Parkwalk Advisors |
Tech stack
Detected on semarion.com, last scanned 24 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4, Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
- Email provider
- Microsoft 365
Semarion scores 19. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Semarion trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Semarion is 77 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Semarion raised?
Semarion has raised a total of $9M in funding. The most recent round on record is Funding Round.
How many employees does Semarion have?
Semarion has approximately 12 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Semarion


